TCM Biotech International Corp. (TPE:4169)
Taiwan · Delayed Price · Currency is TWD 149.00
-1.50 (-1.00%)
Sep 8, 2026, 1:30 PM CST
TCM Biotech International Balance Sheet
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 896.73 | 245.07 | 232.98 | 504.13 | 89.85 | 58.26 |
Short-Term Investments | 300.09 | 300 | 300 | - | 0.09 | - |
Cash & Short-Term Investments | 1,197 | 545.07 | 532.98 | 504.13 | 89.94 | 58.26 |
Cash Growth | 126.27% | 2.27% | 5.72% | 460.55% | 54.38% | 70.01% |
Accounts Receivable | 161.18 | 151.37 | 139.96 | 259.08 | 225.83 | 190.68 |
Other Receivables | 0.87 | 0.13 | 1.69 | 3.61 | 3.94 | 0.03 |
Receivables | 162.05 | 151.5 | 141.65 | 262.69 | 229.77 | 190.71 |
Inventory | 189.91 | 156.13 | 132.24 | 208.36 | 193.25 | 203.33 |
Prepaid Expenses | 11.24 | 5.67 | 4.96 | 4.46 | 0.65 | 17.08 |
Other Current Assets | 1.18 | 0.1 | 0.15 | 1.51 | 0.13 | 0.74 |
Total Current Assets | 1,561 | 858.46 | 811.98 | 981.15 | 513.74 | 470.11 |
Property, Plant & Equipment | 271.44 | 280.67 | 291.91 | 293.71 | 301.74 | 285.36 |
Long-Term Investments | 229.91 | 27.52 | 30 | - | - | - |
Other Intangible Assets | 4.32 | 1.92 | 5.06 | 8.01 | 10.24 | 13.21 |
Long-Term Deferred Tax Assets | 1.44 | 1.32 | 1.02 | 0.98 | 1.63 | 4.2 |
Long-Term Deferred Charges | 15.66 | 15.66 | 15.66 | 15.66 | 15.66 | 16.26 |
Other Long-Term Assets | 20.3 | 18.63 | 26.73 | 23.41 | 19.87 | 30.92 |
Total Assets | 2,104 | 1,204 | 1,182 | 1,323 | 862.87 | 820.06 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 53.86 | 48.38 | 20.69 | 64.53 | 88.81 | 55.54 |
Accrued Expenses | 19.48 | 27.66 | 26.47 | 50.18 | 52.01 | 36.84 |
Short-Term Debt | - | - | - | 44 | 44 | 44 |
Current Portion of Long-Term Debt | 1.27 | 3.45 | 3.05 | 5.19 | 10.44 | 9.21 |
Current Portion of Leases | 3.09 | 3.9 | 3.72 | 1.68 | 2.95 | 1.84 |
Current Income Taxes Payable | - | 3.39 | 4.03 | 2.59 | 2.35 | - |
Current Unearned Revenue | 17.84 | 10.29 | 2.84 | 2.25 | 2.76 | 5.12 |
Other Current Liabilities | 38.12 | 17.83 | 21.11 | 27.96 | 21.54 | 23.38 |
Total Current Liabilities | 133.66 | 114.89 | 81.9 | 198.38 | 224.84 | 175.93 |
Long-Term Debt | 8.32 | 24.76 | 28.54 | 59.69 | 93.58 | 104.51 |
Long-Term Leases | 3.86 | 5.09 | 8.16 | 4.81 | 6.49 | 1.45 |
Long-Term Unearned Revenue | 3.23 | 3.23 | 3.23 | 3.23 | - | 18.2 |
Pension & Post-Retirement Benefits | - | 0.89 | 1.46 | 1.5 | 1 | 1.6 |
Long-Term Deferred Tax Liabilities | - | - | 0 | - | 0.01 | - |
Other Long-Term Liabilities | 0.76 | - | - | 0.27 | 0.27 | 0.16 |
Total Liabilities | 149.82 | 148.86 | 123.28 | 267.88 | 326.2 | 301.84 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 664.32 | 590.49 | 590.49 | 590.49 | 475.92 | 475.92 |
Additional Paid-In Capital | 1,335 | 415.77 | 415.77 | 415.77 | 13.82 | 13.82 |
Retained Earnings | -4.45 | 51.63 | 52.87 | 48.85 | 47.04 | 28.47 |
Comprehensive Income & Other | -40.25 | -2.57 | -0.05 | -0.07 | -0.11 | 0.01 |
Shareholders' Equity | 1,954 | 1,055 | 1,059 | 1,055 | 536.67 | 518.22 |
Total Liabilities & Equity | 2,104 | 1,204 | 1,182 | 1,323 | 862.87 | 820.06 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 16.55 | 37.2 | 43.46 | 115.38 | 157.46 | 161 |
Net Cash (Debt) | 1,180 | 507.87 | 489.52 | 388.76 | -67.52 | -102.75 |
Net Cash Growth | 141.49% | 3.75% | 25.92% | - | - | - |
Net Cash Per Share | 19.37 | 8.60 | 8.29 | 7.33 | -1.38 | -2.11 |
Filing Date Shares Outstanding | 66.43 | 59.05 | 59.05 | 59.05 | 49.05 | 49.05 |
Total Common Shares Outstanding | 66.43 | 59.05 | 59.05 | 59.05 | 49.05 | 49.05 |
Working Capital | 1,428 | 743.57 | 730.08 | 782.78 | 288.9 | 294.18 |
Book Value Per Share | 29.42 | 17.87 | 17.94 | 17.87 | 10.94 | 10.57 |
Tangible Book Value | 1,950 | 1,053 | 1,054 | 1,047 | 526.43 | 505.01 |
Tangible Book Value Per Share | 29.36 | 17.84 | 17.85 | 17.73 | 10.73 | 10.30 |
Land | 83.08 | 83.08 | 83.08 | 83.08 | 83.08 | 83.08 |
Buildings | 197.04 | 197.04 | 197.04 | 196.97 | 196.6 | 194.3 |
Machinery | 110.78 | 109.96 | 105.32 | 101.48 | 93.09 | 77.69 |
Leasehold Improvements | 14.39 | 14.39 | 14.39 | 10.33 | 9.76 | 3.41 |